2023 Agenda

Friday, October 6



7:00 am – Villard Foyer

Registration & Morning Coffee

8:20 am – Villard Ballroom

Welcome Back
Sara Jane Demy, Founder & CEO, Demy-Colton

8:30 am – Villard Ballroom

Opening “Big Think” Plenary Session
A Fireside Chat with Andy Plump:
What Will It Take to Deliver Cures to Society
Our unprecedented knowledge of human biology and disease is unlocking the potential to treat—and even cure—devastating diseases like never before. Simultaneously, innovations in data, digital and technology are revolutionizing our ability to discover, develop and deliver transformational medicines to patients. Explore what it will take to leverage the powerful technical tools at our disposal to bring the next generation of transformational medicines to patients.

Seema Kumar, CEO, Cure

Andy Plump, MD, PhD, President of R&D, Takeda

9:30 am
Adams/Kennedy I/Kennedy II

Presenting Companies

9:30 am – 12:30 pm


10:30 am – Holmes I

Dialogue 4A
New Tactics to Turn Off Cancer

Jay Campbell, Managing Director, Clinical Accelerator & Venture Fund, Cancer Research Institute (CRI)

Roy de Souza, CEO, BreakBio
Michael Goldberg, PhD, CEO, SURGE Therapeutics 
Anthony Johnson, CEO, Kodikaz 
Wyatt J. McDonnell, PhD, CEO, Infinimmune 
Mani Mohindru, PhD, CEO & Director, Novasenta

10:30 am – Holmes II

Dialogue 4B
Seeding the Future:
Financing Tech and Bio for Mind-blowing Breakthroughs

George Santo, Executive Director – Middle Market Life Sciences Commercial Banking, JPMorgan

Milad Alucozai, DrPH, Head, Bio and Deep Tech, BoxOne Ventures
Laurence Blumberg, MD, Biotechnology Executive; Lecturer, Weill Cornell Medicine
Olga Danilchanka, PhD, Principal, MRL Ventures Fund, Merck
Kayj Shannon, Venture Partner, Alix Ventures

11:15 am
Adams/Kennedy I/Kennedy II

Presenting Companies

12:30 pm – Villard Ballroom

“Big Think” Lunch Plenary
Navigating the Biotech Landscape in a Difficult Market

Tim Opler, PhD, Managing Director, Global Healthcare Group, Stifel

Sal Saraceno, Managing Director, Healthcare Investment, Capital One
Brad Sitko, Chief Investment Officer, XOMA
Robert Williamson, President & COO, Triumvira
Hanadie Yousef, PhD, CEO & Co-Founder, Juvena

2:00 pm
Adams/Kennedy I/Kennedy II

Presenting Companies

2:00 pm – 3:45 pm


3:00 pm – Holmes I

Dialogue 5A
Alzheimer’s Disease:
A Brighter Horizon – Are We Turning the Corner on This Intractable Disease

Virginia Amann, Founder/Shareholder ENTENTE Network

Jonathan Behr, PhD, Partner, Dementia Discovery Fund (DDF)
Marc Jones, CEO, Altoida
Brent Vaughan, CEO, Cognito

3:00 pm – Holmes II

Dialogue 5B
Infectious Disease:
From Neglect to Respect Made Possible by New Technologies

Steve Brozak, DMH, Managing Partner & President, WBB Securities

Rick Bright, PhD, Pandemic Prevention & Response
Steven Damon, CEO, Micron Biomedical
Elizabeth Kavaler, MD, Founding Partner, Total Urology Care of New York
Karim Lalji, CEO, Microbion

3:45 pm – Villard Ballroom

Closing “Big Think" Plenary
Heard Around the Street:
What’s Buzzing in Biotech

Kimberly Ha, CEO & Founder, KKH Advisors

Max Bayer, Reporter, Fierce Biotech
Hilary Brueck, Correspondent, Insider
Julianna LeMieux, PhD, Deputy Editor in Chief, GEN
Sony Salzman, Coordinating Producer, Medical Unit, ABC News

5:00 pm – Villard Foyer

Closing Reception

Be a part of BioFuture

© 2022 BioFutureTM. All Rights Reserved

Produced by